Frenchay Hospital
Welcome,         Profile    Billing    Logout  
 7 Trials 
2 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Person, Contact
NCT03412643: Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling

Recruiting
2
64
US
Doxorubicin, Cyclophosphamide, Weekly Paclitaxel, Trastuzumab, Pertuzumab, Celcuity CELx HSF
NSABP Foundation Inc, Celcuity, LLC, Genentech, Inc.
HER2-negative Breast Cancer
10/23
10/23
Barnfield, Steven
IMPACT, NCT05444465: Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears

Recruiting
N/A
234
Europe, Canada, US, RoW
Isolated Bioinductive Repair, REGENETEN™ Bioinductive Implant, Completion and Repair
Smith & Nephew, Inc.
Rotator Cuff Injuries
08/26
06/28
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Person, Contact
NCT03412643: Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling

Recruiting
2
64
US
Doxorubicin, Cyclophosphamide, Weekly Paclitaxel, Trastuzumab, Pertuzumab, Celcuity CELx HSF
NSABP Foundation Inc, Celcuity, LLC, Genentech, Inc.
HER2-negative Breast Cancer
10/23
10/23
Barnfield, Steven
IMPACT, NCT05444465: Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears

Recruiting
N/A
234
Europe, Canada, US, RoW
Isolated Bioinductive Repair, REGENETEN™ Bioinductive Implant, Completion and Repair
Smith & Nephew, Inc.
Rotator Cuff Injuries
08/26
06/28

Download Options